Filing Flows › ImageneBio (IMA) › Q1 2025
ImageneBio (IMA) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 8, 2025
ImageneBio (IMA) reported revenue of $800K for the first quarter 2025 (Q1 2025).
ImageneBio, Q1 2025: revenue $800K, net loss $8.6M, operating cash flow −$10.6M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $800K | — | — |
| Operating profit | −$10.8M | — | — |
| Net earnings | −$8.6M | — | — |
| Operating cash flow | −$10.6M | — | — |
What changed
Revenue was $800K in Q1 2025.
Operating costs exceeded revenue by $10.8M, an operating margin of -1349.2%. The quarter ended with a net loss of $8.6M. Non-operating items added $2.2M, -26% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$10.6M. Non-cash charges added back $2K of depreciation and amortization and $904K of share-based compensation. Working capital and other items used $2.8M.
Questions
What was ImageneBio's revenue in the first quarter 2025?
ImageneBio (IMA) reported revenue of $800K for the first quarter 2025 (Q1 2025).
Source: ImageneBio 10-Q on SEC EDGAR.